시장보고서
상품코드
1806070

광학 유전체 매핑(OGM) 시장 규모, 점유율, 성장 분석, 제품별, 방법별, 최종 용도별, 컴포넌트별, 지역별 - 산업 예측(2025-2032년)

Optical Genome Mapping Market Size, Share, and Growth Analysis, By Product (Instruments, Consumables & Reagents), By Technique (Structural Variant Detection, Genome Assembly), By End-Use, By Component, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 182 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

광학 유전체 매핑(OGM) 세계 시장 규모는 2023년에 1억 1,590만 달러로 평가되었습니다. 예측 기간(2025년-2032년) CAGR은 21.2%로, 2024년 1억 4,047만 달러에서 2032년까지는 6억 5,404만 달러로 성장할 전망입니다.

광학 유전체 매핑(OGM) 시장은 쇼트 리드 시퀀싱으로는 효과적으로 대응할 수 없는 복잡한 구조적 변이체를 안정적으로 식별하고자 하는 연구소가 증가함에 따라 크게 성장하고 있습니다. 시료 비용을 줄이면서 처리량을 향상시키는 화학 및 플로우 셀 기술의 혁신과 함께, 장비 배치 및 시약 대여 옵션의 확대로 접근성이 향상되고 있습니다. 벤더는 자동화, 클라우드 기반 분석, 표준화된 보고를 통해 워크플로우를 최적화하고 종양학, 혈액 악성 종양, 희귀질환, 세포 및 유전자 치료의 품질 관리에서 재현성을 촉진하고 있습니다. 연구 시험에서 광범위한 응용으로 채택이 확대됨에 따라, 초점은 소모품, 소프트웨어, 서비스로 옮겨가고 있습니다. 주요 동향으로는 OGM과 NGS의 하이브리드 보고, AI를 통한 변이체 콜링, 집중 분석 네트워크 구축 등이 있으며, OGM은 전 세계 바이오제약 및 연구소에 필수적인 유전체 특성 분석 도구로 자리매김하고 있습니다.

목차

서론

  • 조사 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차와 1차 데이터 방법
  • 시장 규모 예측
  • 시장 전제조건과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porter의 Five Forces 분석

주요 시장 인사이트

  • 주요 성공 요인
  • 경쟁 정도
  • 주요 투자 기회
  • 시장 생태계
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석
  • 규제 분석
  • 기술 분석
  • 사례 연구

광학 유전체 매핑(OGM) 시장 규모 : 제품 및 서비스별·CAGR(2025년-2032년)

  • 시장 개요
  • 기기
  • 소모품 및 시약
  • 소프트웨어 및 서비스

광학 유전체 매핑(OGM) 시장 규모 : 기술별·CAGR(2025년-2032년)

  • 시장 개요
  • 구조 변이 감지
  • 유전체 어셈블리
  • 미생물 균주 타이핑
  • 희귀 변이 식별

광학 유전체 매핑(OGM) 시장 규모 : 최종 용도별·CAGR(2025년-2032년)

  • 시장 개요
  • 바이오테크놀러지 및 제약회사
  • 병원 및 임상 실험실
  • 학술기관
  • 계약 연구기관(CRO)

광학 유전체 매핑(OGM) 시장 규모 : 컴포넌트별·CAGR(2025년-2032년)

  • 시장 개요
  • 하드웨어
  • 소프트웨어

광학 유전체 매핑(OGM) 시장 규모·CAGR(2025년-2032년)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채택한 전략
  • 최근 시장 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업 개요
    • 기업 상세
    • 제품 포트폴리오 분석
    • 기업 부문별 점유율 분석
    • 매출 전년대비 비교(2022년-2024년)

주요 기업 개요

  • Bionano Genomics
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Illumina
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Qiagen
  • Roche
  • Bio-Rad Laboratories
  • Revvity(PerkinElmer)
  • Cytiva(Danaher)
  • 10x Genomics

결론과 제안

LSH 25.09.16

Global Optical Genome Mapping Market size was valued at USD 115.9 million in 2023 and is poised to grow from USD 140.47 million in 2024 to USD 654.04 million by 2032, growing at a CAGR of 21.2% during the forecast period (2025-2032).

The market for Optical Genome Mapping (OGM) is witnessing substantial growth as laboratories increasingly seek reliable identification of complex structural variants that short-read sequencing cannot effectively address. Enhanced access is driven by the expansion of instrument placements and reagent rental options, alongside innovations in chemistry and flow cell technology that boost throughput while reducing sample costs. Vendors are optimizing workflows through automation, cloud-based analysis, and standardized reporting, fostering reproducibility across oncology, hematologic malignancies, rare diseases, and cell-and-gene therapy quality control. As adoption broadens from research trials to widespread application, focus shifts towards consumables, software, and services. Key trends include hybrid OGM and NGS reporting, AI-driven variant calling, and the establishment of centralized analysis networks, solidifying OGM's position as a vital genome characterization tool for biopharma and laboratories worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Optical Genome Mapping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Optical Genome Mapping Market Segments Analysis

Global Optical Genome Mapping Market is segmented by Product, Technique, End-Use, Component and region. Based on Product, the market is segmented into Instruments, Consumables & Reagents and Software and Services. Based on Technique, the market is segmented into Structural Variant Detection, Genome Assembly, Microbial Strain Typing and Rare Variant Identification. Based on End-Use, the market is segmented into Biotech & Pharma Companies, Hospitals & Clinical Labs, Academic Institutes and Contract Research Organizations (CROs). Based on Component, the market is segmented into Hardware and Software. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Optical Genome Mapping Market

The growth of the global optical genome mapping market is significantly driven by laboratories adopting comprehensive end-to-end processes that seamlessly integrate optical genome mapping with sequencing, allowing them to tackle complex genomic rearrangements effectively. The establishment of standardized pipelines, the use of reference samples, and the development of detailed interpretative guidelines enable consistent and reproducible results across various locations. Additionally, with larger patient cohorts and evolving reporting necessities, the frequency of repeat kit usage rises. The introduction of cloud-based analysis further accelerates turnaround times and enhances staff productivity, particularly for multi-site implementations, thereby fueling market expansion.

Restraints in the Global Optical Genome Mapping Market

The global optical genome mapping market faces several constraints, primarily due to the requirement for specialized expertise in triaging, classifying, and reporting structural variants. Smaller cohorts often encounter a steep learning curve related to analysis and quality control, with audit documentation adding to their workload. Without standardized cloud solutions and comprehensive standard operating procedures, inconsistencies between different sites can arise, which hampers operational efficiency and impedes the transition from research pilots to established service lines. Such challenges pose significant obstacles to the expansion and growth of the market, limiting its overall share in the industry.

Market Trends of the Global Optical Genome Mapping Market

The global Optical Genome Mapping (OGM) market is witnessing a notable trend towards hybrid solutions that combine OGM with sequencing technologies for comprehensive genome characterization. This integration facilitates enhanced detection of large genomic rearrangements alongside precise identification of breakpoints and variants, promoting a more nuanced understanding of genetic anomalies. The adoption of shared reporting pipelines and harmonized reference sets drives efficiency in analysis, reducing review cycles and increasing concordance among multidisciplinary teams in fields like oncology, hematology, and constitutional genetics. Such advancements not only enhance diagnostic accuracy but also foster collaborative decision-making, establishing a strong momentum for market growth.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Analysis
  • Technology Analysis
  • Case Studies

Global Optical Genome Mapping Market Size by Product & Service & CAGR (2025-2032)

  • Market Overview
  • Instruments
  • Consumables & Reagents
  • Software and Services

Global Optical Genome Mapping Market Size by Technique & CAGR (2025-2032)

  • Market Overview
  • Structural Variant Detection
  • Genome Assembly
  • Microbial Strain Typing
  • Rare Variant Identification

Global Optical Genome Mapping Market Size by End-Use & CAGR (2025-2032)

  • Market Overview
  • Biotech & Pharma Companies
  • Hospitals & Clinical Labs
  • Academic Institutes
  • Contract Research Organizations (CROs)

Global Optical Genome Mapping Market Size by Component & CAGR (2025-2032)

  • Market Overview
  • Hardware
  • Software

Global Optical Genome Mapping Market Size & CAGR (2025-2032)

  • North America (Product & Service, Technique, End-Use, Component)
    • US
    • Canada
  • Europe (Product & Service, Technique, End-Use, Component)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product & Service, Technique, End-Use, Component)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product & Service, Technique, End-Use, Component)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product & Service, Technique, End-Use, Component)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Bionano Genomics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacific Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Nanopore Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revvity (PerkinElmer)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cytiva (Danaher)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 10x Genomics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제